Impact of the combined timing of PD-1/PD-L1 inhibitors and chemotherapy on the outcomes in patients with refractory lung cancer
2021 · ESMO Open · 24 citations
https://doi.org/10.1016/j.esmoop.2021.100094
Krirk University(TH)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
40
Citations
3
h-index
1
i10-index
Meiyue Zhang is an academic researcher from Krirk University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Essential Oils and Antimicrobial Activity & Synthesis and biological activity. The author has an h-index of 3, co-authored 6 publications.
Click to start Chat